Annual Accounts Payable
$33.51 M
-$12.34 M-26.92%
31 December 2023
Summary:
Core Laboratories NV annual accounts payable is currently $33.51 million, with the most recent change of -$12.34 million (-26.92%) on 31 December 2023. During the last 3 years, it has risen by +$10.48 million (+45.50%). CLB annual accounts payable is now -41.87% below its all-time high of $57.64 million, reached on 31 December 2011.CLB Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Accounts Payable
$33.63 M
-$3.24 M-8.78%
30 September 2024
Summary:
Core Laboratories NV quarterly accounts payable is currently $33.63 million, with the most recent change of -$3.24 million (-8.78%) on 30 September 2024. Over the past year, it has dropped by -$470.00 thousand (-1.38%). CLB quarterly accounts payable is now -45.17% below its all-time high of $61.33 million, reached on 30 June 2011.CLB Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CLB Accounts Payable Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -26.9% | -1.4% |
3 y3 years | +45.5% | -4.0% |
5 y5 years | -18.6% | -20.3% |
CLB Accounts Payable High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3 years | -26.9% | +45.5% | -26.6% | +13.1% |
5 y | 5 years | -26.9% | +45.5% | -26.6% | +47.5% |
alltime | all time | -41.9% | +520.5% | -45.2% | +1020.9% |
Core Laboratories NV Accounts Payable History
Date | Annual | Quarterly |
---|---|---|
Sept 2024 | - | $33.63 M(-8.8%) |
June 2024 | - | $36.86 M(+13.5%) |
Mar 2024 | - | $32.49 M(-3.0%) |
Dec 2023 | $33.51 M(-26.9%) | $33.51 M(-1.7%) |
Sept 2023 | - | $34.10 M(-12.9%) |
June 2023 | - | $39.15 M(+2.0%) |
Mar 2023 | - | $38.37 M(-16.3%) |
Dec 2022 | $45.85 M(+54.2%) | $45.85 M(+33.5%) |
Sept 2022 | - | $34.34 M(-4.9%) |
June 2022 | - | $36.11 M(+4.9%) |
Mar 2022 | - | $34.41 M(+15.7%) |
Dec 2021 | $29.73 M(+29.1%) | $29.73 M(-15.1%) |
Sept 2021 | - | $35.02 M(+15.2%) |
June 2021 | - | $30.38 M(+19.1%) |
Mar 2021 | - | $25.50 M(+10.7%) |
Dec 2020 | $23.03 M(-35.3%) | $23.03 M(+1.0%) |
Sept 2020 | - | $22.81 M(-3.7%) |
June 2020 | - | $23.69 M(-36.1%) |
Mar 2020 | - | $37.05 M(+4.1%) |
Dec 2019 | $35.61 M(-13.5%) | $35.61 M(-15.6%) |
Sept 2019 | - | $42.19 M(+0.5%) |
June 2019 | - | $41.99 M(-5.6%) |
Mar 2019 | - | $44.47 M(+8.0%) |
Dec 2018 | $41.16 M(-1.3%) | $41.16 M(+0.3%) |
Sept 2018 | - | $41.01 M(-9.4%) |
June 2018 | - | $45.28 M(-0.6%) |
Mar 2018 | - | $45.54 M(+9.2%) |
Dec 2017 | $41.70 M(+23.7%) | $41.70 M(+19.5%) |
Sept 2017 | - | $34.90 M(-16.1%) |
June 2017 | - | $41.61 M(+14.1%) |
Mar 2017 | - | $36.48 M(+8.2%) |
Dec 2016 | $33.72 M(+0.7%) | $33.72 M(+4.7%) |
Sept 2016 | - | $32.20 M(+9.5%) |
June 2016 | - | $29.40 M(-15.4%) |
Mar 2016 | - | $34.75 M(+3.8%) |
Dec 2015 | $33.47 M(-28.9%) | $33.47 M(-17.4%) |
Sept 2015 | - | $40.54 M(-4.2%) |
June 2015 | - | $42.32 M(-17.0%) |
Mar 2015 | - | $51.00 M(+8.3%) |
Dec 2014 | $47.08 M(-7.4%) | $47.08 M(-5.2%) |
Sept 2014 | - | $49.65 M(-3.2%) |
June 2014 | - | $51.29 M(-4.5%) |
Mar 2014 | - | $53.72 M(+5.7%) |
Dec 2013 | $50.82 M(-7.9%) | $50.82 M(-5.7%) |
Sept 2013 | - | $53.90 M(-3.6%) |
June 2013 | - | $55.93 M(+3.4%) |
Mar 2013 | - | $54.08 M(-2.0%) |
Dec 2012 | $55.17 M(-4.3%) | $55.17 M(+20.5%) |
Sept 2012 | - | $45.78 M(-10.7%) |
June 2012 | - | $51.28 M(+6.4%) |
Mar 2012 | - | $48.19 M(-16.4%) |
Dec 2011 | $57.64 M(+28.9%) | $57.64 M(+23.2%) |
Sept 2011 | - | $46.78 M(-23.7%) |
June 2011 | - | $61.33 M(+25.8%) |
Mar 2011 | - | $48.75 M(+9.0%) |
Dec 2010 | $44.71 M | $44.71 M(+16.1%) |
Sept 2010 | - | $38.51 M(-2.6%) |
June 2010 | - | $39.53 M(+8.2%) |
Date | Annual | Quarterly |
---|---|---|
Mar 2010 | - | $36.53 M(+10.7%) |
Dec 2009 | $33.01 M(-20.6%) | $33.01 M(+18.0%) |
Sept 2009 | - | $27.98 M(+4.3%) |
June 2009 | - | $26.84 M(-1.4%) |
Mar 2009 | - | $27.22 M(-34.6%) |
Dec 2008 | $41.59 M(+4.3%) | $41.59 M(+6.3%) |
Sept 2008 | - | $39.11 M(+1.1%) |
June 2008 | - | $38.68 M(+8.4%) |
Mar 2008 | - | $35.69 M(-10.5%) |
Dec 2007 | $39.86 M(+6.4%) | $39.86 M(-12.6%) |
Sept 2007 | - | $45.60 M(-5.5%) |
June 2007 | - | $48.25 M(+44.0%) |
Mar 2007 | - | $33.51 M(-10.5%) |
Dec 2006 | $37.46 M(+15.1%) | $37.46 M(+21.7%) |
Sept 2006 | - | $30.77 M(-8.7%) |
June 2006 | - | $33.70 M(+11.8%) |
Mar 2006 | - | $30.15 M(-7.4%) |
Dec 2005 | $32.56 M(+13.7%) | $32.56 M(+21.4%) |
Sept 2005 | - | $26.81 M(-3.7%) |
June 2005 | - | $27.85 M(-4.0%) |
Mar 2005 | - | $29.00 M(+1.3%) |
Dec 2004 | $28.63 M(+12.3%) | $28.63 M(+11.9%) |
Sept 2004 | - | $25.59 M(+6.1%) |
June 2004 | - | $24.12 M(+10.2%) |
Mar 2004 | - | $21.89 M(-14.1%) |
Dec 2003 | $25.49 M(+0.3%) | $25.49 M(+3.3%) |
Sept 2003 | - | $24.67 M(+7.0%) |
June 2003 | - | $23.06 M(-8.3%) |
Mar 2003 | - | $25.15 M(-1.0%) |
Dec 2002 | $25.41 M(+28.8%) | $25.41 M(+63.3%) |
Sept 2002 | - | $15.56 M(+1.5%) |
June 2002 | - | $15.34 M(-3.8%) |
Mar 2002 | - | $15.95 M(-19.1%) |
Dec 2001 | $19.72 M(-23.9%) | $19.72 M(+14.2%) |
Sept 2001 | - | $17.27 M(-15.8%) |
June 2001 | - | $20.53 M(+8.5%) |
Mar 2001 | - | $18.92 M(-27.0%) |
Dec 2000 | $25.93 M(+31.1%) | $25.93 M(+28.8%) |
Sept 2000 | - | $20.14 M(-3.8%) |
June 2000 | - | $20.94 M(+12.6%) |
Mar 2000 | - | $18.61 M(-5.9%) |
Dec 1999 | $19.77 M(-0.6%) | $19.77 M(+25.2%) |
Sept 1999 | - | $15.80 M(+8.2%) |
June 1999 | - | $14.60 M(-12.6%) |
Mar 1999 | - | $16.70 M(-16.1%) |
Dec 1998 | $19.90 M(-14.2%) | $19.90 M(+43.2%) |
Sept 1998 | - | $13.90 M(-48.1%) |
June 1998 | - | $26.80 M(+104.6%) |
Mar 1998 | - | $13.10 M(-43.5%) |
Dec 1997 | $23.20 M(+293.2%) | $23.20 M(+79.8%) |
Sept 1997 | - | $12.90 M(+4.0%) |
June 1997 | - | $12.40 M(+63.2%) |
Mar 1997 | - | $7.60 M(+28.8%) |
Dec 1996 | $5.90 M(+9.3%) | $5.90 M(+78.8%) |
Sept 1996 | - | $3.30 M(-17.5%) |
June 1996 | - | $4.00 M(+33.3%) |
Mar 1996 | - | $3.00 M(-44.4%) |
Dec 1995 | $5.40 M | $5.40 M(+14.9%) |
Sept 1995 | - | $4.70 M |
FAQ
- What is Core Laboratories NV annual accounts payable?
- What is the all time high annual accounts payable for Core Laboratories NV?
- What is Core Laboratories NV annual accounts payable year-on-year change?
- What is Core Laboratories NV quarterly accounts payable?
- What is the all time high quarterly accounts payable for Core Laboratories NV?
- What is Core Laboratories NV quarterly accounts payable year-on-year change?
What is Core Laboratories NV annual accounts payable?
The current annual accounts payable of CLB is $33.51 M
What is the all time high annual accounts payable for Core Laboratories NV?
Core Laboratories NV all-time high annual accounts payable is $57.64 M
What is Core Laboratories NV annual accounts payable year-on-year change?
Over the past year, CLB annual accounts payable has changed by -$12.34 M (-26.92%)
What is Core Laboratories NV quarterly accounts payable?
The current quarterly accounts payable of CLB is $33.63 M
What is the all time high quarterly accounts payable for Core Laboratories NV?
Core Laboratories NV all-time high quarterly accounts payable is $61.33 M
What is Core Laboratories NV quarterly accounts payable year-on-year change?
Over the past year, CLB quarterly accounts payable has changed by -$470.00 K (-1.38%)